Using a panel of 24 adult adult T cell lymphoma patients, the vast majority of PBMCs from these subjects (22/24) were shown to express CCR4 by PCR and to respond to CCL17 and CCL22 in chemotaxis assays (Yoshie et al., 2002). This evidence concerns the gene CCR4 and T-cell non-Hodgkin lymphoma.